This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 0V43
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de LexaGene Holdings Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.16 |
| 52 Week High | CA$0.25 |
| 52 Week Low | CA$0.16 |
| Beta | 2.25 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -86.67% |
| Change since IPO | -84.00% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 0V43 | GB Medical Equipment | Mercado GB | |
|---|---|---|---|
| 7D | 0% | 1.7% | 0.7% |
| 1Y | n/a | -9.2% | 3.0% |
Rentabilidad vs. Industria: Insufficient data to determine how 0V43 performed against the UK Medical Equipment industry.
Rentabilidad vs. Mercado: Insufficient data to determine how 0V43 performed against the UK Market.
Volatilidad de los precios
| 0V43 volatility | |
|---|---|
| 0V43 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: 0V43 has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine 0V43's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2007 | 33 | Jack Regan | www.lexagene.com |
Resumen de fundamentos de LexaGene Holdings Inc.
| Estadísticas fundamentales de 0V43 | |
|---|---|
| Capitalización bursátil | CA$14.78m |
| Beneficios(TTM) | -CA$11.50m |
| Ingresos (TTM) | CA$140.41k |
105.2x
Ratio precio-ventas (PS)-1.3x
Ratio precio-beneficio (PE)¿Está 0V43 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 0V43 | |
|---|---|
| Ingresos | US$104.27k |
| Coste de los ingresos | US$757.46k |
| Beneficio bruto | -US$653.19k |
| Otros gastos | US$7.89m |
| Beneficios | -US$8.54m |
Últimos beneficios comunicados
Nov 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.061 |
| Margen bruto | -626.46% |
| Margen de beneficio neto | -8,189.91% |
| Ratio deuda/patrimonio | 66.4% |
¿Cómo se ha desempeñado 0V43 a largo plazo?
Ver rendimiento histórico y comparativa